Balance Sheet Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-17 pm EST			5-day change	1st Jan Change
12.39 ^USD	-1.04%		-16.45%	-9.63%

Jan. 15	Myriad Genetics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 03:45 PM
Jan. 15	Myriad Genetics Expects Higher Q4 Revenue, Provides 2025 Guidance	MT

df9502d39.iDjZL_1tVvH0q2ra6zqFZjeVth_e67No161Q6GDBaco.-U-DTM4IIIGdwSDtmHf9S2T__Cmrsdkjmv4ZhAiABJ37d4ZtlFw-mqf9Kw

Published financial data: MYRIAD GENETICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	851M	600M	691M	678M	753M
Total Revenues	851M	600M	691M	678M	753M
Cost of Goods Sold, Total	201M	183M	198M	202M	236M
Gross Profit	650M	417M	493M	476M	517M
Selling General & Admin Expenses, Total	535M	514M	538M	515M	567M
R&D Expenses	85.9M	71.6M	81.9M	85.4M	88.7M
Other Operating Expenses, Total	621M	585M	620M	600M	656M
Operating Income	29.5M	-169M	-127M	-124M	-139M
Interest Expense, Total	-12M	-11.6M	-6.6M	-3.2M	-2.9M
Interest And Investment Income	3.2M	1.4M	700K	2.6M	2.5M
Net Interest Expenses	-8.8M	-10.2M	-5.9M	-600K	-400K
Currency Exchange Gains (Loss)	-	-	-	-	-3.4M
Other Non Operating Income (Expenses)	1.2M	-2.4M	-600K	600K	500K
EBT, Excl. Unusual Items	21.9M	-181M	-133M	-124M	-142M
Merger & Related Restructuring Charges	-20.8M	-	-	-	-
Impairment of Goodwill	-	-82M	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-1.5M
Gain (Loss) On Sale Of Assets	-	1M	152M	-	-
Asset Writedown	-	-17.7M	-1.8M	-16.9M	-5.7M
Legal Settlements	-	-	-62M	-	-113M
Other Unusual Items	-1.1M	-7M	-11.7M	-	-
EBT, Incl. Unusual Items	0	-188M	-57.1M	-141M	-262M
Income Tax Expense	-4.4M	-82M	-29.9M	-28.6M	1.1M
Earnings From Continuing Operations	4.4M	-106M	-27.2M	-112M	-263M
Net Income to Company	4.4M	-106M	-27.2M	-112M	-263M
Minority Interest	200K	100K	-	-	-
Net Income - (IS)	4.6M	-106M	-27.2M	-112M	-263M
Net Income to Common Incl Extra Items	4.6M	-106M	-27.2M	-112M	-263M
Net Income to Common Excl. Extra Items	4.6M	-106M	-27.2M	-112M	-263M
Per Share Items
Net EPS - Basic	0.06	-1.42	-0.35	-1.39	-3.18
Basic EPS - Continuing Operations	0.06	-1.42	-0.35	-1.39	-3.18
Basic Weighted Average Shares Outstanding	73.5M	75M	78M	80.6M	82.8M
Net EPS - Diluted	0.06	-1.42	-0.35	-1.39	-3.18
Diluted EPS - Continuing Operations	0.06	-1.42	-0.35	-1.39	-3.18
Diluted Weighted Average Shares Outstanding	76M	75M	78M	80.6M	82.8M
Normalized Basic EPS	0.19	-1.51	-1.07	-0.96	-1.07
Normalized Diluted EPS	0.18	-1.51	-1.07	-0.96	-1.07
Supplemental Items
EBITDA	102M	-97M	-63.9M	-71M	-82.7M
EBITA	88.8M	-107M	-76M	-82.6M	-96.1M
EBIT	29.5M	-169M	-127M	-124M	-139M
EBITDAR	122M	-38.6M	-43.2M	-	-56.8M
Total Revenues (As Reported)	851M	600M	691M	678M	753M
Effective Tax Rate - (Ratio)	-	43.57	52.36	20.34	-0.42
Current Domestic Taxes	-24.3M	-153M	1.7M	1.4M	5.2M
Current Foreign Taxes	200K	400K	100K	500K	200K
Total Current Taxes	-24.1M	-152M	1.8M	1.9M	5.4M
Deferred Domestic Taxes	-	71.4M	-	-	-
Deferred Foreign Taxes	-	-1M	-	-	-
Total Deferred Taxes	19.7M	70.4M	-31.7M	-30.9M	-4.3M
Normalized Net Income	13.89M	-113M	-83.25M	-77.31M	-88.88M
Interest on Long-Term Debt	12M	5.8M	6.6M	3.2M	2.9M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	85.9M	71.6M	81.9M	85.4M	88.7M
Net Rental Expense, Total	19.7M	9.9M	20.7M	-	25.9M
Imputed Operating Lease Interest Expense	15.58M	6.02M	5.73M	-	4.04M
Imputed Operating Lease Depreciation	4.12M	12.38M	14.97M	-	21.86M
Stock-Based Comp., COGS (Total)	1M	1.4M	1.6M	1.7M	1.4M
Stock-Based Comp., R&D Exp. (Total)	5.4M	4.8M	4.2M	5.2M	4M
Stock-Based Comp., SG&A Exp. (Total)	27.1M	23.6M	30.5M	31.2M	35.3M
Total Stock-Based Compensation	33.5M	29.8M	36.3M	38.1M	40.7M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	93.2M	117M	258M	56.9M	132M
Short Term Investments	43.7M	33.7M	81.4M	58M	8.8M
Total Cash And Short Term Investments	137M	151M	340M	115M	141M
Accounts Receivable, Total	134M	89.5M	91.3M	102M	114M
Other Receivables	4.7M	2M	-	-	-
Total Receivables	139M	91.5M	91.3M	102M	114M
Inventory	31.4M	27.1M	15.3M	20.1M	22M
Prepaid Expenses	41.7M	120M	38.4M	38M	35.2M
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	-	-	-	-	1.2M
Total Current Assets	349M	389M	485M	275M	314M
Gross Property Plant And Equipment	169M	213M	232M	296M	300M
Accumulated Depreciation	-112M	-113M	-107M	-109M	-120M
Net Property Plant And Equipment	57.3M	100M	125M	187M	181M
Long-term Investments	54.9M	21M	59M	54.8M	-
Goodwill	417M	329M	239M	287M	287M
Other Intangibles, Total	685M	576M	411M	387M	354M
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	-	2.3M	1.6M	8.4M	10.8M
Total Assets	1.56B	1.42B	1.32B	1.2B	1.15B
Liabilities
Accounts Payable, Total	33.3M	20.5M	29.6M	28.8M	25.8M
Accrued Expenses, Total	66.8M	62.1M	77.5M	70.2M	75.7M
Current Portion of Leases	-	13.6M	13M	14.1M	16.2M
Current Income Taxes Payable	3M	4.3M	4M	4.8M	4.6M
Unearned Revenue Current, Total	2.2M	32.7M	5.2M	-	-
Other Current Liabilities	12.5M	12.7M	75M	19.3M	33.6M
Total Current Liabilities	118M	146M	204M	137M	156M
Long-Term Debt	234M	225M	-	-	38.5M
Long-Term Leases	-	50.6M	79.3M	131M	97.4M
Pension & Other Post Retirement Benefits	6.8M	-	-	-	-
Deferred Tax Liability Non Current	82.6M	71.3M	35.8M	3.5M	-
Other Non Current Liabilities	33.1M	45.2M	33.5M	41.3M	71.5M
Total Liabilities	474M	538M	353M	313M	363M
Common Stock, Total	700K	800K	800K	800K	900K
Additional Paid In Capital	1.07B	1.11B	1.23B	1.26B	1.42B
Retained Earnings	25.6M	-227M	-254M	-366M	-630M
Comprehensive Income and Other	-5.4M	-2.3M	-5.1M	-8.9M	-3.7M
Total Common Equity	1.09B	881M	968M	886M	783M
Minority Interest	-	-	-	-	-
Total Equity	1.09B	881M	968M	886M	783M
Total Liabilities And Equity	1.56B	1.42B	1.32B	1.2B	1.15B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	73.87M	76.3M	80.02M	81.22M	89.87M
ECS Total Common Shares Outstanding	73.5M	75.4M	80M	81.2M	89.9M
Book Value / Share	14.81	11.68	12.1	10.91	8.71
Tangible Book Value	-13M	-24.7M	318M	212M	142M
Tangible Book Value Per Share	-0.18	-0.33	3.97	2.61	1.58
Total Debt	234M	289M	92.3M	145M	152M
Net Debt	41.7M	117M	-306M	-24.7M	11.2M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-100K	-	-	-	-
Debt Equivalent Oper. Leases	158M	147M	166M	-	207M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	-	27.1M	15.3M	20.1M	22M
Land - (BS)	2.3M	-	-	-	-
Buildings, Total	18.8M	-	-	-	-
Machinery, Total	117M	118M	112M	125M	148M
Full Time Employees	2.6K	2.7K	2.4K	2.6K	2.7K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	4.6M	-106M	-27.2M	-112M	-263M
Depreciation & Amortization - CF	13.7M	10M	12.1M	11.6M	13.4M
Amortization of Goodwill and Intangible Assets - (CF)	59.3M	61.6M	50.7M	41.1M	42.8M
Depreciation & Amortization, Total	73M	71.6M	62.8M	52.7M	56.2M
(Gain) Loss From Sale Of Asset	-900K	-200K	-162M	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	1.5M
Asset Writedown & Restructuring Costs	-	99.7M	1.8M	16.9M	5.7M
Stock-Based Compensation (CF)	33.5M	29.8M	36.3M	38.1M	40.7M
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	10.6M	121M	-13.9M	-500K	21.3M
Change In Accounts Receivable	-18.2M	-42.8M	-8.8M	-10.3M	-12.5M
Change In Inventories	8M	4.4M	1.6M	-2.9M	-1.8M
Change In Accounts Payable	1.1M	-2.4M	9.2M	-3.5M	-3.7M
Change in Unearned Revenues	-500K	-400K	-26.6M	-5M	-200K
Change In Income Taxes	-25.1M	-217M	89.9M	700K	700K
Change in Other Net Operating Assets	-2.4M	-5.6M	55.1M	-80.5M	44.5M
Cash from Operations	83.7M	-147M	18.2M	-106M	-111M
Capital Expenditure	-8.6M	-15.8M	-18M	-45.3M	-63.2M
Cash Acquisitions	-278M	-	-	-57.2M	-
Divestitures	-	21.3M	379M	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-10.1M
Investment in Marketable and Equity Securities, Total	700K	71.8M	-86.7M	25M	105M
Cash from Investing	-286M	56M	274M	-77.5M	31.9M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	340M	-	-	-	80M
Total Debt Issued	340M	-	-	-	80M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-115M	-8.6M	-226M	-	-40.2M
Total Debt Repaid	-115M	-8.6M	-226M	-	-40.2M
Issuance of Common Stock	8.7M	3.6M	91.8M	6.3M	6M
Repurchase of Common Stock	-50M	-7.6M	-11.5M	-10.6M	-8.8M
Other Financing Activities, Total	-1.4M	-200K	-4.5M	-3.7M	116M
Cash from Financing	182M	-4.2M	-151M	-8M	153M
Foreign Exchange Rate Adjustments	2.7M	2.2M	-600K	-600K	600K
Net Change in Cash	-17.7M	-93.4M	141M	-192M	74.5M
Supplemental Items
Cash Interest Paid	11.6M	10.4M	4.4M	-	1.4M
Cash Income Tax Paid (Refund)	6.5M	3.6M	-85.4M	1.8M	1.9M
Levered Free Cash Flow	59.74M	110M	150M	-116M	-61.42M
Unlevered Free Cash Flow	67.24M	116M	155M	-114M	-59.61M
Change In Net Working Capital	49.1M	-114M	-153M	81.9M	-3.6M
Net Debt Issued / Repaid	225M	-8.6M	-226M	-	39.8M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	1.35	-5.68	-5.78	-6.14	-7.4
Return on Total Capital	1.6	-6.65	-7.1	-7.4	-8.83
Return On Equity %	0.43	-19.89	-2.94	-12.08	-31.55
Return on Common Equity	0.45	-19.88	-2.94	-12.08	-31.55
Margin Analysis
Gross Profit Margin %	76.38	69.51	71.39	70.22	68.64
SG&A Margin	62.82	85.69	77.87	75.87	75.31
EBITDA Margin %	12.04	-16.18	-9.25	-10.47	-10.98
EBITA Margin %	10.43	-17.85	-11	-12.18	-12.76
EBIT Margin %	3.47	-28.12	-18.35	-18.23	-18.44
Income From Continuing Operations Margin %	0.52	-17.71	-3.94	-16.51	-34.96
Net Income Margin %	0.54	-17.71	-3.94	-16.51	-34.96
Net Avail. For Common Margin %	0.54	-17.71	-3.94	-16.51	-34.96
Normalized Net Income Margin	1.63	-18.89	-12.05	-11.4	-11.8
Levered Free Cash Flow Margin	7.02	17.15	21.79	-17.06	-8.16
Unlevered Free Cash Flow Margin	7.9	18.2	22.39	-16.76	-7.91
Asset Turnover
Asset Turnover	0.62	0.43	0.5	0.54	0.64
Fixed Assets Turnover	16.94	7.97	6.12	4.34	4.09
Receivables Turnover (Average Receivables)	7.29	6.32	7.64	7.03	6.98
Inventory Turnover (Average Inventory)	6.12	6.15	9.32	11.41	11.22
Short Term Liquidity
Current Ratio	2.96	2.67	2.37	2	2.01
Quick Ratio	2.34	1.66	2.11	1.58	1.64
Operating Cash Flow to Current Liabilities	0.71	-1.01	0.09	-0.77	-0.71
Days Sales Outstanding (Average Receivables)	50.05	57.89	47.78	51.89	52.31
Days Outstanding Inventory (Average Inventory)	59.65	59.49	39.16	31.98	32.53
Average Days Payable Outstanding	54.63	54.76	49.21	51.54	41.85
Cash Conversion Cycle (Average Days)	55.07	62.62	37.73	32.34	42.99
Long Term Solvency
Total Debt/Equity	21.44	32.8	9.54	16.37	19.42
Total Debt / Total Capital	17.66	24.7	8.71	14.07	16.26
LT Debt/Equity	21.44	31.26	8.19	14.78	17.35
Long-Term Debt / Total Capital	17.66	23.54	7.48	12.7	14.53
Total Liabilities / Total Assets	30.32	37.91	26.72	26.1	31.69
EBIT / Interest Expense	2.46	-14.53	-19.2	-38.66	-47.9
EBITDA / Interest Expense	8.54	-8.36	-6.55	-15.72	-19.59
(EBITDA - Capex) / Interest Expense	7.82	-9.72	-9.27	-29.88	-41.38
Total Debt / EBITDA	2.28	-2.98	-2.14	-2.88	-2.68
Net Debt / EBITDA	0.41	-1.21	7.09	0.49	-0.2
Total Debt / (EBITDA - Capex)	2.49	-2.56	-1.51	-1.52	-1.27
Net Debt / (EBITDA - Capex)	0.44	-1.04	5.01	0.26	-0.09
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.44	-24.97	23.99	-1.77	11.03
</